R01 GM114179/GM/NIGMS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2014	1
2015	3
2016	4
2017	5
2018	3
2019	9
2020	7
2021	4
2022	4
2023	2
2024	2
2025	0

1

Quantitative characterization of in vitro bystander effect of antibody-drug conjugates.

Singh AP, Sharma S, Shah DK. Singh AP, et al. J Pharmacokinet Pharmacodyn. 2016 Dec;43(6):567-582. doi: 10.1007/s10928-016-9495-8. Epub 2016 Sep 26. J Pharmacokinet Pharmacodyn. 2016. PMID: 27670282 Free PMC article.

2

Quantitative systems toxicology.

Bloomingdale P, Housand C, Apgar JF, Millard BL, Mager DE, Burke JM, Shah DK. Bloomingdale P, et al. Curr Opin Toxicol. 2017 Jun;4:79-87. doi: 10.1016/j.cotox.2017.07.003. Epub 2017 Aug 2. Curr Opin Toxicol. 2017. PMID: 29308440 Free PMC article.

3

Pharmacokinetics of protein and peptide conjugates.

Bumbaca B, Li Z, Shah DK. Bumbaca B, et al. Drug Metab Pharmacokinet. 2019 Feb;34(1):42-54. doi: 10.1016/j.dmpk.2018.11.001. Epub 2018 Nov 22. Drug Metab Pharmacokinet. 2019. PMID: 30573392 Free PMC article. Review.

4

Whole-Body Disposition and Physiologically Based Pharmacokinetic Modeling of Adeno-Associated Viruses and the Transgene Product.

Liu S, Chowdhury EA, Xu V, Jerez A, Mahmood L, Ly BQ, Le HK, Nguyen A, Rajwade A, Meno-Tetang G, Shah DK. Liu S, et al. J Pharm Sci. 2024 Jan;113(1):141-157. doi: 10.1016/j.xphs.2023.10.005. Epub 2023 Oct 5. J Pharm Sci. 2024. PMID: 37805073

5

Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.

Shah DK. Shah DK. J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):553-71. doi: 10.1007/s10928-015-9447-8. Epub 2015 Sep 15. J Pharmacokinet Pharmacodyn. 2015. PMID: 26373957 Free PMC article. Review.

6

HER2/ERBB2 immunoreactivity in human retinoblastoma.

Seigel GM, Sharma S, Hackam AS, Shah DK. Seigel GM, et al. Tumour Biol. 2016 May;37(5):6135-42. doi: 10.1007/s13277-015-4475-y. Epub 2015 Nov 27. Tumour Biol. 2016. PMID: 26614428 Free PMC article.

7

Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics.

Liu S, Shah DK. Liu S, et al. Drug Metab Dispos. 2022 Jun;50(6):867-878. doi: 10.1124/dmd.121.000460. Epub 2022 Feb 23. Drug Metab Dispos. 2022. PMID: 35197311 Free PMC article. Review.

8

Pharmacokinetics of AAV9 Mediated Trastuzumab Expression in Rat Brain Following Systemic and Local Administration.

Chowdhury EA, Ahuja M, Wu S, Liu S, Huang HW, Kumar M, Sunkara KS, Ghobrial A, Chandran J, Jamier T, Perkinton M, Meno-Tetang G, Shah DK. Chowdhury EA, et al. J Pharm Sci. 2024 Jan;113(1):131-140. doi: 10.1016/j.xphs.2023.08.023. Epub 2023 Sep 1. J Pharm Sci. 2024. PMID: 37659717

9

Antibody pharmacokinetics in rat brain determined using microdialysis.

Chang HY, Morrow K, Bonacquisti E, Zhang W, Shah DK. Chang HY, et al. MAbs. 2018 Aug/Sep;10(6):843-853. doi: 10.1080/19420862.2018.1473910. Epub 2018 Aug 6. MAbs. 2018. PMID: 29944439 Free PMC article.

10

Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans.

Jagdale P, Sepp A, Shah DK. Jagdale P, et al. J Pharmacokinet Pharmacodyn. 2022 Dec;49(6):607-624. doi: 10.1007/s10928-022-09824-w. Epub 2022 Oct 20. J Pharmacokinet Pharmacodyn. 2022. PMID: 36266517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year